Here's Wouldn't Touch Moderna: Why I Won't Bet on Its Next Growth Engine
Moderna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
Easy expense tracking combines automation, simple categorization, and a minimal workflow to keep your finances accurate without the hassle.
13,940 articlesModerna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
As biotech manufacturing accelerates, repligen (rgen) 2025 earnings will shape how investors price the stock. This gu...
Bitcoin, Ethereum, and Solana jumped as analysts flagged a pause in the '10 a.m. dump' after a Jane Street lawsuit, m...
Looking at Royal Caribbean in 2026, investors want clarity: is it a buy, hold, or sell? This guide breaks down the ca...
CoreWeave delivered stronger top-line growth but a widening loss and cautious quarterly guidance. Investors reacted w...
A DTCC update effective March 2, 2026 unlocks post-trade routing of institutional volumes to the XRP Ledger, as Rippl...
Veeva Systems prepares to unveil Q4 FY2026 after the bell, with investors weighing durable renewals against software ...
Netflix stock gained 15.3% last month as the streaming giant rebounded from a choppy start. This article unpacks the ...
Richtech Robotics faced a dramatic sell-off last month as legal issues and a disappointing earnings report rattled in...
Fidelity's Dividend ETF for Rising Rates has surged 23% over the last year, but the fund’s tech-heavy, rate-sensitive...
As velocity financial readies its quarterly release, investors seek clues about growth, profitability, and risk. This...
A fresh, no-copy analysis of Joint (JYNT) 2025 earnings, focusing on Q4 results, margin trends, and the roadmap for 2...